List of Tables
Table 1. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Disease-Modifying Antirheumatic Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Disease-Modifying Antirheumatic Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Disease-Modifying Antirheumatic Drug Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Disease-Modifying Antirheumatic Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Disease-Modifying Antirheumatic Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Disease-Modifying Antirheumatic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Disease-Modifying Antirheumatic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Disease-Modifying Antirheumatic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Disease-Modifying Antirheumatic Drug Sales by Region (2020-2025) & (MT)
Table 18. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2020-2025)
Table 19. Global Disease-Modifying Antirheumatic Drug Sales by Region (2026-2031) & (MT)
Table 20. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2026-2031)
Table 21. Global Disease-Modifying Antirheumatic Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Disease-Modifying Antirheumatic Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Disease-Modifying Antirheumatic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Disease-Modifying Antirheumatic Drug Sales by Country (2020-2025) & (MT)
Table 27. North America Disease-Modifying Antirheumatic Drug Sales by Country (2026-2031) & (MT)
Table 28. North America Disease-Modifying Antirheumatic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Disease-Modifying Antirheumatic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Disease-Modifying Antirheumatic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2020-2025) & (MT)
Table 32. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2026-2031) & (MT)
Table 33. Europe Disease-Modifying Antirheumatic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Disease-Modifying Antirheumatic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2020-2025) & (MT)
Table 42. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2026-2031) & (MT)
Table 43. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Disease-Modifying Antirheumatic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Disease-Modifying Antirheumatic Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Disease-Modifying Antirheumatic Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2020-2025)
Table 51. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2026-2031)
Table 52. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2020-2025)
Table 53. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2026-2031)
Table 54. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2020-2025)
Table 59. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2026-2031)
Table 60. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2020-2025)
Table 61. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2026-2031)
Table 62. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2020-2025)
Table 63. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2026-2031)
Table 64. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2020-2025)
Table 69. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2026-2031)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. AbbVie Disease-Modifying Antirheumatic Drug Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Amgen Disease-Modifying Antirheumatic Drug Product
Table 79. Amgen Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Pfizer Disease-Modifying Antirheumatic Drug Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Roche Holding AG Company Information
Table 86. Roche Holding AG Description and Business Overview
Table 87. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Roche Holding AG Disease-Modifying Antirheumatic Drug Product
Table 89. Roche Holding AG Recent Developments/Updates
Table 90. Novartis International AG Company Information
Table 91. Novartis International AG Description and Business Overview
Table 92. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Novartis International AG Disease-Modifying Antirheumatic Drug Product
Table 94. Novartis International AG Recent Developments/Updates
Table 95. Johnson & Johnson Company Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Bristol-Myers Squibb Company Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product
Table 104. Bristol-Myers Squibb Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Merck Disease-Modifying Antirheumatic Drug Product
Table 109. Merck Recent Developments/Updates
Table 110. UCB S.A. Company Information
Table 111. UCB S.A. Description and Business Overview
Table 112. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. UCB S.A. Disease-Modifying Antirheumatic Drug Product
Table 114. UCB S.A. Recent Developments/Updates
Table 115. Eli Lilly and Company Company Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Disease-Modifying Antirheumatic Drug Distributors List
Table 123. Disease-Modifying Antirheumatic Drug Customers List
Table 124. Disease-Modifying Antirheumatic Drug Market Trends
Table 125. Disease-Modifying Antirheumatic Drug Market Drivers
Table 126. Disease-Modifying Antirheumatic Drug Market Challenges
Table 127. Disease-Modifying Antirheumatic Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Disease-Modifying Antirheumatic Drug
Figure 2. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Share by Type: 2024 & 2031
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Steroidal Anti-Inflammatory Drugs Product Picture
Figure 6. Slow Acting Drug Product Picture
Figure 7. Immunological Preparation Product Picture
Figure 8. Global Disease-Modifying Antirheumatic Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Disease-Modifying Antirheumatic Drug Market Share by Application: 2024 & 2031
Figure 10. Pharmaceutical Industry
Figure 11. Hospital and Clinic
Figure 12. Other
Figure 13. Global Disease-Modifying Antirheumatic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Disease-Modifying Antirheumatic Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Disease-Modifying Antirheumatic Drug Sales (2020-2031) & (MT)
Figure 16. Global Disease-Modifying Antirheumatic Drug Average Price (USD/MT) & (2020-2031)
Figure 17. Disease-Modifying Antirheumatic Drug Report Years Considered
Figure 18. Disease-Modifying Antirheumatic Drug Sales Share by Manufacturers in 2024
Figure 19. Global Disease-Modifying Antirheumatic Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Disease-Modifying Antirheumatic Drug Players: Market Share by Revenue in Disease-Modifying Antirheumatic Drug in 2024
Figure 21. Disease-Modifying Antirheumatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Disease-Modifying Antirheumatic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2020-2031)
Figure 24. North America Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2020-2031)
Figure 36. China Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Disease-Modifying Antirheumatic Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Disease-Modifying Antirheumatic Drug by Type (2020-2031)
Figure 58. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2020-2031)
Figure 59. Global Sales Market Share of Disease-Modifying Antirheumatic Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Disease-Modifying Antirheumatic Drug by Application (2020-2031)
Figure 61. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2020-2031)
Figure 62. Disease-Modifying Antirheumatic Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
